Candel Therapeutics, Inc. - CADL Future Profit

CADL (Candel Therapeutics Inc.) - company brandmark

Candel Therapeutics (CADL) is attracting top scientists to create breakthrough therapies, while strategic alliances with clinics ensure the long-term growth of biotech developments. The company's profit trajectory visualizes this balance, where the 0.01 metric serves as the target level. Current quotes already price in trial risks, awaiting the publication of final patient survival data.

CADL: Candel Therapeutics Future Profit 11/19/2024 - 12/18/2024

Candel Therapeutics Inc. - analytical breakdowns and key metrics (CADL)

- price and consensus price forecast:
Fundamental company analysis:Candel Therapeutics Inc., CADL
Core merchandise of Candel Therapeutics, Inc.

This indicator measures the discrete revaluation of future cash flows, filtering out market noise to determine the true fundamental value of the business through projected profitability. By analyzing analyst earnings expectations, an investor can assess the resilience of Candel Therapeutics (CADL), whose unique oncolytic therapy system and closed network of clinics create high barriers to entry for competitors, justifying long-term capital investments.

Analysis of competing companies

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings ARAY|SLS - Expected Net Profit|Projected Future Earnings ACTU (Actuate Therapeutics Inc)|Company Profit Forecast Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Projected Future Earnings|Expected Net Profit Protara Therapeutics, Inc.|FATE: Projected Future Earnings|WHWK - Company Profit Forecast|Expected Profit TScan Therapeutics, Inc.|Champions Oncology - Forward Earnings|Projected Future Earnings XBIT|Company Profit Forecast CEL-SCI Corp|Expected Profit OS Therapies OSTX|Expected Net Income RADX|artivabio.com - Projected Future Earnings|Expected Net Income ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Future Profit|TPST: Future Net Profit|XLO (Xilio) - Projected Future Earnings|renovarobio.com (RENB) - Company Profit Forecast|Expected Profit Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Expected Net Income|Projected Future Earnings OKUR (OnKure Therapeutics, Inc.)|Expected Net Income GDTC|Curis Inc. - Projected Future Earnings|APLM (apollomicsinc.com) - Net Profit Forecast|THAR: Projected Future Earnings|Expected Net Profit Advanced Biomed Inc. (ADVB)|Expected Profit Genprex, Inc|Projected Future Earnings calidibio.com|Expected Profit Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit